Radioactive seed implants plus systemic therapy for growing spots in lung or colorectal cancer
Part of Cancer, Digestive system, Lungs & breathing clinical trials.
This study is testing a treatment that implants tiny radioactive seeds (brachytherapy) directly into a few growing cancer spots, along with your regular systemic therapy, for people with lung or colorectal cancer that has spread. It aims to control those growing spots and potentially improve how long the treatment keeps working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with non-small cell lung cancer (NSCLC) or colorectal cancer (CRC) that has spread to other parts of the body.
- You have up to 5 cancer spots that are growing, while the rest of the cancer is stable or under control.
- You have already received at least one form of standard cancer treatment that goes through the whole body (like chemo or targeted therapy).
- Your doctor agrees that the spots can be safely treated with a procedure that implants tiny radioactive seeds directly into them.
- You are generally able to care for yourself (score 0-2 on the ECOG scale) and have adequate organ function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people with solid tumors that have spread to a few spots (5 or fewer) in the body. It tests whether using a focused treatment like radiation or ablation on those spots can help control the cancer long-term.
This study tests a combination approach for people with cancer that has spread to multiple spots outside the brain. It uses a procedure that places tiny radioactive seeds directly into the tumor, along with standard systemic therapy (like chemo or immunotherapy), to see if this helps control the cancer better.
This study combines tiny radioactive seeds placed directly into tumors with an immunotherapy drug that helps the immune system fight cancer. It is for patients with advanced or returning tumors that have not responded well to other treatments, and aims to see if this combination can shrink tumors and improve outcomes.
This trial uses PET/CT scans to precisely place tiny radioactive seeds inside your tumor. The goal is to deliver the right amount of radiation directly to the cancer while sparing healthy tissue, potentially improving treatment effectiveness and reducing side effects.
This trial tests a procedure where tiny radioactive seeds are placed into spinal tumors to relieve pain and control growth. It is for people with cancer that has spread to the bone and who are able to undergo the procedure safely.
This trial tests a combination of two local treatments for people with many or large tumors that have spread. The goal is to control the tumors and possibly improve outcomes without surgery.
Hear when a new Oligometastatic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.